The most frequently studied putative molecular biological prognostic factors in ovarian cancer are the tumor suppressor protein 53 (p53), the oncogenes epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER-2/neu). This evidence concerns the gene ERBB2 and ovarian carcinoma.